Anticancer palladium-doped magnesia nanoparticles: synthesis, characterization, and in vitro study

Nanomedicine ◽  
2020 ◽  
Vol 15 (6) ◽  
pp. 547-561
Author(s):  
Mohamed Qasim Al-Fahdawi ◽  
Abdullah Rasedee ◽  
Faris AJ Al-Doghachi ◽  
Rozita Rosli ◽  
Yun Hun Taufiq-Yap ◽  
...  
Keyword(s):  
In Vitro Study ◽  
Precipitation Method ◽  
Cytochrome C Release ◽  
Mgo Nanoparticles ◽  
Anticancer Effects ◽  
Palladium Acetylacetonate ◽  
Induced Apoptosis ◽  
Co Precipitation ◽  
Anticancer Compound

Aim: To prepare, physicochemically characterize and determine the anticancer effects of palladium-doped magnesia (Pd/MgO) nanoparticles. Materials & methods: Pd/MgO nanoparticles were prepared by the co-precipitation method from the aqueous solution of Mg(NO3)2.6H2O using K2CO3 and the impregnation of MgO into palladium acetylacetonate. Results: Pd/MgO nanoparticles were between 47 and 70 nm in size, cuboid in shape, and tended to form aggregates. Nanoparticles were more antiproliferative toward cancer than the normal cells. In cancer cells, Pd/MgO nanoparticles induced apoptosis by increasing caspase activities and stimulating cytochrome C release. The anticancer effects of Pd/MgO nanoparticles were accentuated by the upregulation of Bax and p53 and downregulation of Bcl-2 protein expressions. Conclusion: Pd/MgO nanoparticles have potential to be developed as an anticancer compound.

Exploring the characterization of Ni doped MgO nanoparticles using co-precipitation method

2020 ◽  
Vol 3 (1) ◽  
pp. 30-33
Author(s):  
Muthulakshmi M ◽  
Madhumitha G
Keyword(s):  
Magnesium Oxide ◽  
Analytical Techniques ◽  
Nickel Chloride ◽  
Precipitation Method ◽  
Crystalline Powder ◽  
High Melting Point ◽  
Design Synthesis ◽  
Mgo Nanoparticles ◽  
Co Precipitation

Nanotechnology is a field of applied science focused on design, synthesis and characterization of nanomaterials. The nickel and magnesium have improved their applications in transparent electrodes and nano electronics. In addition, magnesium oxide has moisture resistance and high melting point properties. In the present work has been carried out in the development of green crystalline powder of nickel doped magnesium oxide nanoparticles by Co-precipitation method, from the mixture of nickel chloride and magnesium chloride with KOH as solvent. From the XRD results, crystalline size of the particle can be observed. Spherical structure of Ni doped MgO nanoparticles were indicated by SEM results and powdered composition of samples were obtained from FTIR. EDAX represents the peak composition of the nanoparticle. The above analytical techniques have confirmed that the Ni doped MgO nanoparticles obtained from the mixture of NiCl2 and MgCl2.

scholarly journals Nitrogen and Bromide Co-Doped Hydroxyapatite Thin Films with Antimicrobial Properties

Coatings ◽  
2021 ◽  
Vol 11 (12) ◽  
pp. 1505
Author(s):  
Simona Liliana Iconaru ◽  
Carmen Steluta Ciobanu ◽  
Daniela Predoi ◽  
Mikael Motelica-Heino ◽  
Constantin Cătălin Negrilă ◽  
...  
Keyword(s):  
Thin Films ◽  
Antimicrobial Activity ◽  
Spin Coating ◽  
Thin Layers ◽  
Precipitation Method ◽  
X Ray ◽  
Co Precipitation ◽  
First Time ◽  
Co Doped

Hydroxyapatite (Ca10(PO4)6(OH)2, HAp), due to its high biocompatibility, is widely used as biomaterial. Doping with various ions of hydroxyapatite is performed to acquire properties as close as possible to the biological apatite present in bones and teeth. In this research the results of a study performed on thin films of hydroxyapatite co-doped with nitrogen and bromine (NBrHAp) are presented for the first time. The NBrHAp suspension was obtained by performing the adapted co-precipitation method using cetyltrimethylammonium bromide (CTAB). The thin layers of NBrHAp were obtained by spin-coating. The stability of the NBrHAp suspension was examined by ultrasound measurements. The thin layers obtained by the spin-coating method were examined by scanning electron microscopy (SEM), optical microscopy (OM), and metallographic microscopy (MM). The presence of nitrogen and bromine were highlighted by energy-dispersive X-ray spectroscopy (EDS) and X-ray photoelectron spectroscopy (XPS) studies. Fourier transform infrared spectroscopy (FTIR) was used to highlight the chemical status of nitrogen and bromine. In addition, the powder obtained from the NBrHAp suspension was analyzed by XRD. Moreover, the in vitro antimicrobial activity of the NBrHAp suspensions and coatings was investigated using the reference microbial strains Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, and Candida albicans ATCC 10231. The results highlighted the successful obtainment of N and Br co-doped hydroxyapatite suspension for the first time by an adapted co-precipitation method. The obtained suspension was used to produce pure NBrHAp composite thin films with superior morphological properties. The NBrHAp suspensions and coatings exhibited in vitro antimicrobial activity against bacterial and fungal strains and revealed their good antimicrobial activity.

scholarly journals The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer Therapy

2019 ◽  
Vol 20 (6) ◽  
pp. 1306 ◽  
Author(s):  
Mario Scheurer ◽  
Roman Brands ◽  
Mohamed El-Mesery ◽  
Stefan Hartmann ◽  
Urs Müller-Richter ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Cell Lines ◽  
In Vitro Study ◽  
Keratinocyte Cell Line Hacat ◽  
Keratinocyte Cell ◽  
Nfκb Pathway ◽  
Induced Apoptosis ◽  
Selection Of ◽  
Hnscc Cell

Inflammation is a central aspect of tumour biology and can contribute significantly to both the origination and progression of tumours. The NFκB pathway is one of the most important signal transduction pathways in inflammation and is, therefore, an excellent target for cancer therapy. In this work, we examined the influence of four NFκB inhibitors—Cortisol, MLN4924, QNZ and TPCA1—on proliferation, inflammation and sensitisation to apoptosis mediated by the death ligand FasL in the HNSCC cell lines PCI1, PCI9, PCI13, PCI52 and SCC25 and in the human dermal keratinocyte cell line HaCaT. We found that the selection of the inhibitor is critical to ensure that cells do not respond by inducing counteracting activities in the context of cancer therapy, e.g., the extreme IL-8 induction mediated by MLN4924 or FasL resistance mediated by Cortisol. However, TPCA1 was qualified by this in vitro study as an excellent therapeutic mediator in HNSCC by four positive qualities: (1) proliferation was inhibited at low μM-range concentrations; (2) TNFα-induced IL-8 secretion was blocked; (3) HNSCC cells were sensitized to TNFα-induced cell death; and (4) FasL-mediated apoptosis was not disrupted.

Europium-Doped Hydroxyapatite: Influence of Excitation Wavelength on the Eu3+ Luminescence in the Hydroxyapatite

2015 ◽  
Vol 820 ◽  
pp. 335-340 ◽  
Author(s):  
Flávia R.O. Silva ◽  
Nelson B. de Lima ◽  
Deiby S. Gouveia ◽  
Nildemar A.M. Ferreira ◽  
Valter Ussui ◽  
...  
Keyword(s):  
Precipitation Method ◽  
Excitation Wavelength ◽  
Careful Evaluation ◽  
Lanthanide Ion ◽  
Site Occupation ◽  
Different Temperatures ◽  
Co Precipitation ◽  
The Eu

Hydroxyapatite (HA) doped with europium (HAEu) offers the advantage of making the hydroxyapatite a fluorescent biomarker, allowing their imaging through emissionin vivoandin vitrotests. Several authors had been based their studies about europium site occupation (CaI and CaII) in hydroxyapatite by the lanthanide ion luminescence, verifying the influence of the method of synthesis and concentration of the dopant ion. In this study HA nanoparticles doped with 1.4 mol% of trivalent europium were synthesized by co-precipitation method and thermal treated at different temperatures (600°C and 1200°C). A careful evaluation of the influence of the excitation wavelength of europium luminescence in the HAEu was performed and it has been verified that both the characteristics transitions of europium, at CaI and CaII sites, and the luminescent intensity are dependent on the excitation wavelength. The non-observance of this fact can lead to erroneous conclusions about the site occupation of europium in hydroxyapatites.

scholarly journals Synergistic antitumor effect of 5-fluorouracil with the novel LSD1 inhibitor ZY0511 in colorectal cancer

2020 ◽  
Vol 12 ◽  
pp. 175883592093742
Author(s):  
Wen Peng ◽  
Huaqing Zhang ◽  
Shisheng Tan ◽  
Yan Li ◽  
Yang Zhou ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Antitumor Effect ◽  
Underlying Mechanism ◽  
Synergistic Antitumor Effect ◽  
Anticancer Effects ◽  
Potential Marker ◽  
And Migration ◽  
Induced Apoptosis

Background: Lysine-specific histone demethylase 1 (LSD1) is a potential target of cancer therapy. In the present study, we aimed to investigate the combined antitumor activity of a novel LSD1 inhibitor (ZY0511) with 5-fluorouracil (5-FU) and elucidate the underlying mechanism in colorectal cancer (CRC). Methods: We evaluated LSD1 expression in CRC tissues from patients who received 5-FU treatment. The synergistic antitumor effect of 5-FU with ZY0511 against human CRC cells was detected both in vitro and in vivo. The underlying mechanism was explored based on mRNA sequencing (mRNA-seq) technology. Results: Overexpression of LSD1 was observed in human CRC tissues, and correlated with CRC development and 5-FU resistance. ZY0511, a novel LSD1 inhibitor, effectively inhibited CRC cells proliferation, both in vitro and in vivo. Notably, the combination of ZY0511 and 5-FU synergistically reduced CRC cells viability and migration in vitro. It also suppressed Wnt/β-catenin signaling and DNA synthesis pathways, which finally induced apoptosis of CRC cells. In addition, the combination of ZY0511 with 5-FU significantly reduced CRC xenograft tumor growth, along with lung and liver metastases in vivo. Conclusions: Our findings identify LSD1 as a potential marker for 5-FU resistance in CRC. ZY0511 is a promising candidate for CRC therapy as it potentiates 5-FU anticancer effects, thereby providing a new combinatorial strategy for treating CRC.

scholarly journals Retinoblastoma protein induction by HIV viremia or CCR5 in monocytes exposed to HIV-1 mediates protection from activation-induced apoptosis: ex vivo and in vitro study

2012 ◽  
Vol 92 (2) ◽  
pp. 397-405 ◽  
Author(s):  
Bethsebah Gekonge ◽  
Andrea D. Raymond ◽  
Xiangfan Yin ◽  
Jay Kostman ◽  
Karam Mounzer ◽  
...  
Keyword(s):  
Ex Vivo ◽  
Retinoblastoma Protein ◽  
In Vitro Study ◽  
Vitro Study ◽  
Induced Apoptosis ◽  
Hiv 1

scholarly journals Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy

2012 ◽  
Vol 303 (9) ◽  
pp. F1264-F1274 ◽  
Author(s):  
Katsuyuki Tanabe ◽  
Yoshifuru Tamura ◽  
Miguel A. Lanaspa ◽  
Makoto Miyazaki ◽  
Norihiko Suzuki ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Kidney Injury ◽  
In Vitro Study ◽  
Protective Effects ◽  
Mitochondrial Fragmentation ◽  
Cytochrome C Release ◽  
Mitochondrial Injury ◽  
Proximal Tubular ◽  
Erk Activity

Cisplatin nephropathy can be regarded as a mitochondrial disease. Intervention to halt such deleterious injury is under investigation. Recently, the flavanol (–)-epicatechin emerges as a novel compound to protect the cardiovascular system, owing in part to mitochondrial protection. Here, we have hypothesized that epicatechin prevents the progression of cisplatin-induced kidney injury by protecting mitochondria. Epicatechin was administered 8 h after cisplatin injury was induced in the mouse kidney. Cisplatin significantly induced renal dysfunction and tubular injury along with an increase in oxidative stress. Mitochondrial damages were also evident as a decrease in loss of mitochondrial mass with a reduction in the oxidative phosphorylation complexes and low levels of MnSOD. The renal damages and mitochondrial injuries were significantly prevented by epicatechin treatment. Consistent with these observations, an in vitro study using cultured mouse proximal tubular cells demonstrated that cisplatin-induced mitochondrial injury, as revealed by a decrease in mitochondrial succinate dehydrogenase activity, an induction of cytochrome c release, mitochondrial fragmentation, and a reduction in complex IV protein, was prevented by epicatechin. Such a protective effect of epicatechin might be attributed to decreased oxidative stress and reduced ERK activity. Finally, we confirmed that epicatechin did not perturb the anticancer effect of cisplatin in HeLa cells. In conclusion, epicatechin exhibits protective effects due in part to its ability to prevent the progression of mitochondrial injury in mouse cisplatin nephropathy. Epicatechin may be a novel option to treat renal disorders associated with mitochondrial dysfunction.

Sign in / Sign up

Export Citation Format

Share Document